{
    "eid": "2-s2.0-85078827610",
    "title": "Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill",
    "cover-date": "2020-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Critical Care and Intensive Care Medicine",
            "@code": "2706",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Atypical HUS",
        "Complement-mediated HUS",
        "Critically ill",
        "Microangiopathy"
    ],
    "authors": [
        "Carlos L. Manrique-Caballero",
        "Sadudee Peerapornratana",
        "Cassandra Formeck",
        "Gaspar Del Rio-Pertuz",
        "Hernando Gomez Danies",
        "John A. Kellum"
    ],
    "citedby-count": 17,
    "ref-count": 139,
    "ref-list": [
        "Atypical hemolytic-uremic syndrome",
        "Syndromes of thrombotic microangiopathy",
        "Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia",
        "Atypical haemolytic uraemic syndrome",
        "Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference",
        "Haemolytic uraemic syndrome",
        "An international consensus approach to the management of atypical hemolytic uremic syndrome in children",
        "Hemolytic uremic syndrome",
        "Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)",
        "German outbreak of Escherichia coli O104:H4 associated with sprouts",
        "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome",
        "Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection",
        "Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature",
        "Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations",
        "Diagnostic approach to microangiopathic hemolytic disorders",
        "Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network",
        "Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006",
        "Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany",
        "Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion",
        "Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression",
        "Update on Streptococcus pneumoniae associated hemolytic uremic syndrome",
        "Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience",
        "Non-enteropathic hemolytic uremic syndrome: causes and short-term course",
        "Thomsen-Friedenreich antigen exposure as a cause of Streptococcus pyogenes-associated hemolytic-uremic syndrome",
        "Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome",
        "Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults",
        "A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience",
        "An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome",
        "Atypical hemolytic uremic syndrome",
        "Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom",
        "Trends in US hospital stays for Streptococcus pneumoniae-associated hemolytic uremic syndrome",
        "Bacterial enteric infections among older adults in the United States: foodborne diseases active surveillance network, 1996-2012",
        "Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis",
        "Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome",
        "An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document",
        "Atypical hemolytic uremic syndrome: from diagnosis to treatment",
        "Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome",
        "None of the above: thrombotic microangiopathy beyond TTP and HUS",
        "How do we approach thrombocytopenia in critically ill patients?",
        "Disseminated intravascular coagulation",
        "Thrombotic thrombocytopenic purpura",
        "HUS and TTP in children",
        "Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome",
        "Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience",
        "The utility of patient characteristics in predicting severe ADAMTS13 deficiency and response to plasma exchange",
        "Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study",
        "Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort",
        "External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment",
        "Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis",
        "Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture",
        "Streptococcus pneumoniae\u2013associated hemolytic uremic syndrome: classification and the emergence of serotype 19A",
        "Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome",
        "Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome",
        "Shiga-toxin producing Escherichia coli in Brazil: a systematic review",
        "Public Health reporting and National Notification for Shiga toxin-producing Escherichia coli (STEC)",
        "Hemolytic uremic syndrome",
        "Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome",
        "Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways",
        "Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics",
        "Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis",
        "The complement system in hemolytic-uremic syndrome in childhood",
        "Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome",
        "Hemolytic uremic syndrome in children",
        "Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry",
        "Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?",
        "Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome",
        "Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota",
        "The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections",
        "Clinical and laboratory consequences of platelet transfusion in shiga toxin-mediated hemolytic uremic syndrome",
        "Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome",
        "Hemoconcentration in hemolytic uremic syndrome: time to review the standard case definition?",
        "Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome",
        "Is plasma exchange efficacious in shiga toxin-associated hemolytic uremic syndrome? A narrative review of current evidence",
        "Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study",
        "Long-term outcomes of Shiga toxin hemolytic uremic syndrome",
        "Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features",
        "Hemolytic uremic syndrome: defining the need for long-term follow-up",
        "Hemolytic uremic syndrome; pathogenesis, treatment, and outcome",
        "Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children",
        "Relationship between Escherichia coli O157:H7 and diabetes mellitus",
        "Central nervous system involvement in hemolytic uremic syndrome (HUS)\u2013a retrospective analysis of cerebral CT and MRI studies",
        "Late onset seizures, hemiparesis and blindness in hemolytic uremic syndrome",
        "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype",
        "Understanding organ dysfunction in thrombotic thrombocytopenic purpura",
        "Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome",
        "Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome",
        "Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome",
        "Factors determining penetrance in familial atypical haemolytic uraemic syndrome",
        "Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?",
        "Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics",
        "Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome",
        "Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation",
        "Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome",
        "Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies",
        "Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP",
        "Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study",
        "Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies",
        "Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome",
        "Terminal complement inhibitor eculizumab in adult patients with atypical hemolytic uremic syndrome: a single-arm, open-label trial",
        "Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference",
        "How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome",
        "Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis",
        "Eculizumab in secondary atypical haemolytic uraemic syndrome",
        "Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia",
        "T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia",
        "The use of a rapid fluorogenic neuraminidase assay to differentiate acute Streptococcus pneumoniae-associated hemolytic uremic syndrome (HUS) from other forms of HUS",
        "Hemolytic uremic syndrome and streptococcus pneumoniae: improving our understanding",
        "Investigating the role of pneumococcal neuraminidase A activity in isolates from pneumococcal haemolytic uraemic syndrome",
        "Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells",
        "Complement depletion and Coombs positivity in pneumococcal hemolytic uremic syndrome (pnHUS). Case series and plea to revisit an old pathogenetic concept",
        "The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome",
        "Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America",
        "Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection",
        "Three-year multicenter surveillance of systemic pneumococcal infections in children",
        "Renal transplantation after Streptococcus pneumoniae-associated hemolytic uremic syndrome",
        "Streptococcus pneumoniae-associated hemolytic uremic syndrome",
        "Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan",
        "Invasive pneumococcal disease and hemolytic uremic syndrome",
        "Streptococcus pneumoniae-associated hemolytic uremic syndrome",
        "T-transformed red cells\u2013role of minor cross-match in patients with T antigen activation",
        "Invasive pneumococcal pneumonia is the major cause of paediatric haemolytic-uraemic syndrome in Taiwan",
        "Positive Coombs test in pneumococcus-associated hemolytic uremic syndrome. A review of the literature",
        "T and Tk antigen activation in necrotising enterocolitis: manifestations, severity of illness, and effectiveness of testing",
        "Therapeutic plasma exchange in Streptococcus pneumoniae-associated hemolytic uremic syndrome: a case report",
        "Streptococcus pneumoniae-associated hemolytic and uremic syndrome with cholestasis: a case report and brief literature review",
        "Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations",
        "Acute kidney injury in pregnancy",
        "Eculizumab in pregnancy-associated atypical hemolytic uremic syndrome: insights for optimizing management",
        "Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab",
        "Eculizumab for atypical hemolytic uremic syndrome in pregnancy",
        "Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient",
        "Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation",
        "A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders",
        "Thrombotic microangiopathy after kidney transplantation",
        "Drug-induced thrombotic microangiopathy: a systematic review of published reports",
        "Drug-induced thrombotic microangiopathy: experience of the Oklahoma Registry and the BloodCenter of Wisconsin",
        "Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome",
        "Quinine-induced thrombotic microangiopathy: a report of 19 patients",
        "Complement. First of two parts"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pittsburgh",
            "@id": "60001361",
            "affilname": "University of Pittsburgh School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001361",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Pittsburgh",
            "@id": "60005708",
            "affilname": "UPMC Children\u2019s Hospital of Pittsburgh",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005708",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "NIH",
        "NIGMS"
    ]
}